<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.2.1" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
	<title>Comments for Rhodes Holdings LLC Blog</title>
	<link>http://s218499049.onlinehome.us</link>
	<description>Taking a public view of finance</description>
	<pubDate>Sat, 21 Nov 2009 14:02:07 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2.1</generator>

	<item>
		<title>Comment on Highlights of Healthcare bill by David Balat, Ph.D.</title>
		<link>http://s218499049.onlinehome.us/2009/07/29/highlights-of-healthcare-bill/#comment-7</link>
		<author>David Balat, Ph.D.</author>
		<pubDate>Wed, 29 Jul 2009 02:56:29 +0000</pubDate>
		<guid>http://s218499049.onlinehome.us/2009/07/29/highlights-of-healthcare-bill/#comment-7</guid>
		<description>&lt;p&gt;I'm fairly convinced that the plan as it stands will not be passed. This is not to say that some form of it will be implemented.  What Obama is pushing, although he admittedly hasn't read it, is the federalization of virtually every aspect of healthcare.  There are portions that recommend limited treatment of heart disease and aggressive cancers for patients over the age of 65.&lt;br&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;In the meantime, the concern that has arisen due to the media blitz on healthcare is that reimbursement is continually being decreased, increased taxes are on the horizon and overhead costs are creeping up due to inflationary factors.  The bottom line of all this to the physician is how can I make more money doing what I'm doing.  Our service addresses that issue which is why we're seeing the kind of growth we've seen in the last two months.&lt;/p&gt;
</description>
		<content:encoded><![CDATA[<p>I&#8217;m fairly convinced that the plan as it stands will not be passed. This is not to say that some form of it will be implemented.  What Obama is pushing, although he admittedly hasn&#8217;t read it, is the federalization of virtually every aspect of healthcare.  There are portions that recommend limited treatment of heart disease and aggressive cancers for patients over the age of 65.</p>
<p>In the meantime, the concern that has arisen due to the media blitz on healthcare is that reimbursement is continually being decreased, increased taxes are on the horizon and overhead costs are creeping up due to inflationary factors.  The bottom line of all this to the physician is how can I make more money doing what I&#8217;m doing.  Our service addresses that issue which is why we&#8217;re seeing the kind of growth we&#8217;ve seen in the last two months.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on SEC Memo from Washington DC SEC counsel by Robert Rhodes</title>
		<link>http://s218499049.onlinehome.us/2008/02/20/sec-memo-from-washington-dc-sec-counsel/#comment-4</link>
		<author>Robert Rhodes</author>
		<pubDate>Thu, 21 Feb 2008 03:01:16 +0000</pubDate>
		<guid>http://s218499049.onlinehome.us/2008/02/20/sec-memo-from-washington-dc-sec-counsel/#comment-4</guid>
		<description>From Michael Paige:
&lt;code&gt;
&lt;strong&gt;Holding periods (for securities that are not initially issued by a "shell" company)&lt;/strong&gt;:

Reporting Issuers [filing 10-K's, 10-Q's etc]

Non-Affiliate: 1st 6 months -- No resales
                  2nd 6 months -- Unlimited Resales as long as issuer has current public information on file
                  After 1 year   -- Unlimited Resales with no other requirements

Affiliates:      1st 6 months   -- No resales
                  After 6 months -- Resales in accordance with all 144 requirements, current public info., volume limit, manner of sale, Form 144

As to non-reporting companies, for non-affiliates no resales are permitted for first year and unlimited resales with no accompanying requirements thereafter; for affiliates no resales are permitted for first year and unlimited resales with all 144 requirements, current public info., volume limit, manner of sale, Form 144 thereafter

&lt;/code&gt;</description>
		<content:encoded><![CDATA[<p>From Michael Paige:<br />
<code><br />
<strong>Holding periods (for securities that are not initially issued by a &#8220;shell&#8221; company)</strong>:</p>
<p>Reporting Issuers [filing 10-K&#8217;s, 10-Q&#8217;s etc]</p>
<p>Non-Affiliate: 1st 6 months &#8212; No resales<br />
                  2nd 6 months &#8212; Unlimited Resales as long as issuer has current public information on file<br />
                  After 1 year   &#8212; Unlimited Resales with no other requirements</p>
<p>Affiliates:      1st 6 months   &#8212; No resales<br />
                  After 6 months &#8212; Resales in accordance with all 144 requirements, current public info., volume limit, manner of sale, Form 144</p>
<p>As to non-reporting companies, for non-affiliates no resales are permitted for first year and unlimited resales with no accompanying requirements thereafter; for affiliates no resales are permitted for first year and unlimited resales with all 144 requirements, current public info., volume limit, manner of sale, Form 144 thereafter</p>
<p></code></p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on SEC Memo from Washington DC SEC counsel by Robert Rhodes</title>
		<link>http://s218499049.onlinehome.us/2008/02/20/sec-memo-from-washington-dc-sec-counsel/#comment-3</link>
		<author>Robert Rhodes</author>
		<pubDate>Wed, 20 Feb 2008 08:38:13 +0000</pubDate>
		<guid>http://s218499049.onlinehome.us/2008/02/20/sec-memo-from-washington-dc-sec-counsel/#comment-3</guid>
		<description>&lt;p&gt;Thank you!  This was very beneficial and helped clarify many new items that the SEC has issued.  One question though was on the new 144 rule time frames - could you clarify that?&lt;/p&gt;
</description>
		<content:encoded><![CDATA[<p>Thank you!  This was very beneficial and helped clarify many new items that the SEC has issued.  One question though was on the new 144 rule time frames - could you clarify that?</p>
]]></content:encoded>
	</item>
</channel>
</rss>
